It's clear that tumors have to be treated effectively, which is something that goes without saying in the way of brain cancer research. Healthy cells, for example, have to be approached carefully while still addressing the issue of cancerous, unhealthy cells. Certain drugs may be put to use but some of them are going to be more helpful than others. This is why I'd like to make note of a recent report that would shed more light on the differentiation between cell types, healthy or otherwise.
Brain cancer research is easily one of the greatest fields of research to consider. There are so many details to take into account, whether it is a matter of the number of potential drugs that can be put to use or what have you. When it comes to surgery, many will tell you that there is a level of risk to be aware of, especially when given the rate of success from one patient to the next. New approaches will be focused on by various organizations, Voices against Brain Cancer included.
YottaFire posted an article that spoke about a particular drug by the name of J101. For those who do not know, this drug - focused on by Cancer Research UK specialists - is one that is able to halt the progression of cancerous cells without bringing any harm to the healthy ones. It is clear that this level of success is a great one and the details go to show it. Of course, you are probably wondering about the specific details related to the actions of J101.
J101's function is to block a cellular "messaging" molecule, a substance by the name of polo-like kinase 1. While this may not be familiar to most, plk1 has the ability to send messages to cancer cells in the body and cause them to multiply and progress, thereby resulting in the growth of tumors later on. J101 was the drug talked about but the report spoke about three new drugs that operate in the same way. Not only are they similar in this regard but they can also cross the bloodstream easier than J101.
I have no question that this particular field will have a great amount of attention drawn to it and I am sure that others feel the same after reading this report. J101 is an effective drug but how positive is it when other drugs have been found, which can potentially prove themselves to be better? There will be many different substances and compounds to talk about in the field of research. It's just a matter of finding the most effective ones that can be put to use later.
Brain cancer research is easily one of the greatest fields of research to consider. There are so many details to take into account, whether it is a matter of the number of potential drugs that can be put to use or what have you. When it comes to surgery, many will tell you that there is a level of risk to be aware of, especially when given the rate of success from one patient to the next. New approaches will be focused on by various organizations, Voices against Brain Cancer included.
YottaFire posted an article that spoke about a particular drug by the name of J101. For those who do not know, this drug - focused on by Cancer Research UK specialists - is one that is able to halt the progression of cancerous cells without bringing any harm to the healthy ones. It is clear that this level of success is a great one and the details go to show it. Of course, you are probably wondering about the specific details related to the actions of J101.
J101's function is to block a cellular "messaging" molecule, a substance by the name of polo-like kinase 1. While this may not be familiar to most, plk1 has the ability to send messages to cancer cells in the body and cause them to multiply and progress, thereby resulting in the growth of tumors later on. J101 was the drug talked about but the report spoke about three new drugs that operate in the same way. Not only are they similar in this regard but they can also cross the bloodstream easier than J101.
I have no question that this particular field will have a great amount of attention drawn to it and I am sure that others feel the same after reading this report. J101 is an effective drug but how positive is it when other drugs have been found, which can potentially prove themselves to be better? There will be many different substances and compounds to talk about in the field of research. It's just a matter of finding the most effective ones that can be put to use later.
About the Author:
For more information about brain cancer research and awareness overall, please consult Voices against Brain Cancer
0 comments:
Post a Comment